577 related articles for article (PubMed ID: 28651783)
1. Optimal Timing of Heart Transplant After HeartMate II Left Ventricular Assist Device Implantation.
Steffen RJ; Blackstone EH; Smedira NG; Soltesz EG; Hoercher KJ; Thuita L; Starling RC; Mountis M; Moazami N
Ann Thorac Surg; 2017 Nov; 104(5):1569-1576. PubMed ID: 28651783
[TBL] [Abstract][Full Text] [Related]
2. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
3. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
4. Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.
Arnaoutakis GJ; George TJ; Kilic A; Weiss ES; Russell SD; Conte JV; Shah AS
J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1236-45, 1245.e1. PubMed ID: 21839482
[TBL] [Abstract][Full Text] [Related]
5. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
6. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
Urban M; Pirk J; Szarszoi O; Besik J; Netuka I
Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235
[TBL] [Abstract][Full Text] [Related]
7. Optimal timing of cardiac transplantation after ventricular assist device implantation.
Gammie JS; Edwards LB; Griffith BP; Pierson RN; Tsao L
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1789-99. PubMed ID: 15173738
[TBL] [Abstract][Full Text] [Related]
8. Gender differences in continuous-flow left ventricular assist device therapy as a bridge to transplantation: a risk-adjusted comparison using a propensity score-matching analysis.
Weymann A; Patil NP; Sabashnikov A; Mohite PN; García Sáez D; Amrani M; Bahrami T; De Robertis F; Wahlers T; Banner NR; Popov AF; Simon AR
Artif Organs; 2015 Mar; 39(3):212-9. PubMed ID: 25175547
[TBL] [Abstract][Full Text] [Related]
9. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation.
Moreno SG; Novielli N; Cooper NJ
J Heart Lung Transplant; 2012 May; 31(5):450-8. PubMed ID: 22115674
[TBL] [Abstract][Full Text] [Related]
11. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
[TBL] [Abstract][Full Text] [Related]
12. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
Radovancevic B; Vrtovec B; de Kort E; Radovancevic R; Gregoric ID; Frazier OH
J Heart Lung Transplant; 2007 Aug; 26(8):815-8. PubMed ID: 17692785
[TBL] [Abstract][Full Text] [Related]
13. Changes in renal function after implantation of continuous-flow left ventricular assist devices.
Hasin T; Topilsky Y; Schirger JA; Li Z; Zhao Y; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Joyce L; Daly R; Park SJ; Kushwaha SS
J Am Coll Cardiol; 2012 Jan; 59(1):26-36. PubMed ID: 22192665
[TBL] [Abstract][Full Text] [Related]
14. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
[TBL] [Abstract][Full Text] [Related]
15. Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support.
Takeda K; Takayama H; Kalesan B; Uriel N; Colombo PC; Jorde UP; Yuzefpolskaya M; Mancini DM; Naka Y
J Heart Lung Transplant; 2015 Jan; 34(1):89-99. PubMed ID: 25444372
[TBL] [Abstract][Full Text] [Related]
16. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
[TBL] [Abstract][Full Text] [Related]
17. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices.
John R; Holley CT; Eckman P; Roy SS; Cogswell R; Harvey L; Shumway S; Liao K
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):363-375. PubMed ID: 28043445
[TBL] [Abstract][Full Text] [Related]
18. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
[TBL] [Abstract][Full Text] [Related]
19. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
[TBL] [Abstract][Full Text] [Related]
20. Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score.
Thomas SS; Nahumi N; Han J; Lippel M; Colombo P; Yuzefpolskaya M; Takayama H; Naka Y; Uriel N; Jorde UP
J Heart Lung Transplant; 2014 Jul; 33(7):675-81. PubMed ID: 24726424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
